These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

59 related items for PubMed ID: 28061430

  • 1. Exploring the characteristics of suboptimally controlled patients after 24weeks of basal insulin treatment: An individualized approach to intensification.
    Khunti K, Damci T, Husemoen LL, Babu V, Liebl A.
    Diabetes Res Clin Pract; 2017 Jan; 123():209-217. PubMed ID: 28061430
    [Abstract] [Full Text] [Related]

  • 2. Safety and effectiveness of insulin detemir in combination with oral antidiabetic agents in an outpatient specialist setting: results of the Italian SOLVE™ observational study.
    Caputo S, Maran A, Mannino D, Morano S, Lastoria G, Nicoziani P.
    Minerva Endocrinol; 2015 Dec; 40(4):249-58. PubMed ID: 26551483
    [Abstract] [Full Text] [Related]

  • 3. Weight-neutral effect of once-daily insulin detemir in Chinese type 2 diabetes patients: subgroup analysis of the SOLVE study.
    Pan C, Han P, Ji L, Ji Q, Lu J, Lin J, Liu J, Su B, Shi J, Wang P.
    J Diabetes; 2015 Mar; 7(2):222-30. PubMed ID: 24909984
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effect of once-daily insulin detemir on oral antidiabetic drug (OAD) use in patients with type 2 diabetes.
    Vora J, Caputo S, Damci T, Orozco-Beltran D, Pan C, Svendsen AL, Sølje KS, Khunti K, SOLVE study group.
    J Clin Pharm Ther; 2014 Apr; 39(2):136-43. PubMed ID: 24329524
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Advancing therapy in type 2 diabetes mellitus with early, comprehensive progression from oral agents to insulin therapy.
    Vinik A.
    Clin Ther; 2007 Apr; 29 Spec No():1236-53. PubMed ID: 18046925
    [Abstract] [Full Text] [Related]

  • 9. A comparison of adding liraglutide versus a single daily dose of insulin aspart to insulin degludec in subjects with type 2 diabetes (BEGIN: VICTOZA ADD-ON).
    Mathieu C, Rodbard HW, Cariou B, Handelsman Y, Philis-Tsimikas A, Ocampo Francisco AM, Rana A, Zinman B, BEGIN: VICTOZA ADD-ON (NN1250-3948) study group.
    Diabetes Obes Metab; 2014 Jul; 16(7):636-44. PubMed ID: 24443830
    [Abstract] [Full Text] [Related]

  • 10. [The safety and effectiveness of once daily detemir in patients with type 2 diabetes previously failing oral agents: the Chinese cohort from SOLVE(TM) observational study].
    Pan CY, Ji LN, Lu JM, Yang WY, Zhou ZG, Zou DJ, Ji QH, Han P, Liu J, Li Q, Su BL, Li YB, Gao ZN, Wang PH, Yin SN, Dong YH, Yang T, Sun K, Li H, Hong X, Lin J, Shi JM, Yang XJ, Fang H, Yan XD, SOLVE™ Chinese study group.
    Zhonghua Nei Ke Za Zhi; 2013 Jan; 52(1):11-5. PubMed ID: 23710808
    [Abstract] [Full Text] [Related]

  • 11. Switching from Premixed Insulin To Basal Insulin Analogue For Type 2 Diabetes and Role of Dipeptidyl Peptidase-4 Inhibitors.
    Gómez-Peralta F, Abreu C, Mora-Navarro G, López-Morandeira P, Pérez-Gutierrez E, Cordero-García B, Brito-Sanfiel M.
    Exp Clin Endocrinol Diabetes; 2018 May; 126(5):268-276. PubMed ID: 28704854
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparison of stepwise addition of prandial insulin to a basal-bolus regimen when basal insulin is insufficient for glycaemic control in type 2 diabetes: results of the OSIRIS study.
    Raccah D, Haak TJ, Huet D, Monnier L, Robertson D, Labard P, Soler J, Penfornis A.
    Diabetes Metab; 2012 Dec; 38(6):507-14. PubMed ID: 23116646
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Evaluating Glycemic Control in Patients with Type 2 Diabetes Suboptimally Controlled on Basal Insulin: UK ATTAIN Real-World Study.
    Jude EB, Nixon M, O'Leary C, Myland M, Gooch N, Shaunik A, Lew E.
    Diabetes Ther; 2019 Oct; 10(5):1847-1858. PubMed ID: 31321748
    [Abstract] [Full Text] [Related]

  • 20. Initiation of once daily insulin detemir is not associated with weight gain in patients with type 2 diabetes mellitus: results from an observational study.
    Yale JF, Damci T, Kaiser M, Karnieli E, Khunti K, Liebl A, Baeres FM, Svendsen AL, Ross SA, SOLVE Study Group.
    Diabetol Metab Syndr; 2013 Oct 02; 5(1):56. PubMed ID: 24499517
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.